Plate Nº 16 · recorded November 15, 2026
Health & Medicine ResearchReported finding
Walking May Cut Deaths 37% After Colon Cancer Treatment
A trial of 889 colon cancer patients found 28% fewer recurrences and 37% fewer deaths among those given a coached exercise program after chemotherapy.
By Marcus Bennett2 min read412 words
In brief
- The CHALLENGE trial (New England Journal of Medicine, 2025) followed 889 colon cancer patients for about eight years.
- Patients offered a three-year coached exercise program had 28% fewer recurrences and 37% fewer deaths.
- Stanford cancer specialists published their review of the evidence on November 13, 2026.
- Mechanisms such as immune recognition of cancer cells remain preliminary research.
- The findings apply to colon cancer and cannot be assumed for breast, lung or other cancers.
Cancer survivors who followed a structured exercise program after colon cancer chemotherapy recorded 37% fewer deaths over roughly eight years than peers who received only educational materials. That is the headline result of the CHALLENGE trial, published in the New England Journal of Medicine in 2025, and it sits at the center of a growing push to rethink rest during cancer recovery.
Stanford University cancer specialists laid out the evidence in a report published on November 13, 2026. Their advice challenges an older convention in oncology: that people with cancer should avoid activity until treatment ends.
What did the CHALLENGE trial actually find?
The trial enrolled 889 patients who had finished chemotherapy for colon cancer. Half received a structured exercise program supported by coaches for three years; the comparison group received educational materials instead of coaching.
After roughly eight years of follow-up, the results were substantial:
- 28% fewer cancer recurrences or new cancers among those offered the exercise program
- 37% fewer deaths overall in the same group
The numbers suggest exercise can influence outcomes beyond comfort or fitness after treatment. This was a well-designed trial in colon cancer specifically, which makes its findings persuasive for that disease.
Why would movement affect cancer outcomes?
Scientists are still working out the biology. Physical activity may help the immune system recognize cancer cells, and it may change conditions in the tissue surrounding tumors. Much of this mechanistic research remains preliminary, so treat these explanations as hypotheses, not established facts.
For patients, the most immediate benefit is different: less fatigue. Exercise may also improve sleep, mood and the capacity to handle everyday tasks. The right amount varies widely from person to person.
How should survivors start?
Nobody needs demanding workouts. A gentle walk, light cycling or simple strengthening exercises offer a practical starting point, with activity dialed back on difficult treatment days.
Safety comes first. People with fragile bones, recent operations, low immunity or other complications should ask their medical team which activities suit them. Specialist cancer rehabilitation programs can help tailor a plan.
What are the limits of the evidence?
The trial's colon cancer findings cannot automatically transfer to breast, lung or other cancers. More direct studies are needed to establish who benefits most and which exercise programs work best.
For now, the evidence supports treating appropriate movement as a partner to medical care, not a substitute for it. Even small, manageable steps can help patients take part in their own recovery.
via knowridge.com (Source)
More from Marcus Bennett
Show full bio
News editor covering regulation, policy and their impact on general science news at SciBeat.
421 articles
Nearby plates
- Exercise Program Boosts Attention and May Slow Aging in Breast Cancer Survivors
- Some High-Fat Diets Boosted Immunotherapy in Mice, McGill Study Finds
- Cancer Rising in Younger Adults, and Obesity Alone Cannot Explain It
- Most Young Colorectal Cancer Patients Are Diagnosed Late, Study Finds
- Turning a Cancer-Driving Protein into an Immune Ally